Skip to main content

Advertisement

Log in

High-dose oral vitamin D3 supplementation in the elderly

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Daily dosing with vitamin D often fails to achieve optimal outcomes, and it is uncertain what the target level of 25-hydroxyvitamin D should be. This study found that large loading doses of vitamin D3 rapidly and safely normalize 25OHD levels, and that monthly dosing is similarly effective after 3–5 months. With baseline 25OHD > 50 nmol/L, vitamin D supplementation does not reduce PTH levels.

Introduction

There is concern that vitamin D supplementation doses are frequently inadequate, and that compliance with daily medication is likely to be suboptimal.

Methods

This randomized double-blind trial compares responses to three high-dose vitamin D3 regimens and estimates optimal 25-hydroxyvitamin D (25OHD) levels, from changes in parathyroid hormone (PTH), and procollagen type I amino-terminal propeptide (P1NP) in relation to baseline 25OHD. Sixty-three elderly participants were randomized to three regimens of vitamin D supplementation: a 500,000-IU loading dose; the loading dose plus 50,000 IU/month; or 50,000 IU/month.

Results

The Loading and Loading + Monthly groups showed increases in 25OHD of 58 ± 28 nmol/L from baseline to 1 month. Thereafter, levels gradually declined to plateaus of 69 ± 5 nmol/L and 91 ± 4 nmol/l, respectively. In the Monthly group, 25OHD reached a plateau of ~80 ± 20 nmol/L at 3–5 months. There were no changes in serum calcium concentrations. PTH and P1NP were only suppressed by vitamin D treatment in those with baseline 25OHD levels <50 and <30 nmol/L, respectively.

Conclusions

Large loading doses of vitamin D3 rapidly and safely normalize 25OHD levels in the frail elderly. Monthly dosing is similarly effective and safe, but takes 3–5 months for plateau 25OHD levels to be reached.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. von Muhlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E (2005) Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: The Rancho Bernardo Study. Osteoporos Int 16:1721–1726

    Article  CAS  Google Scholar 

  2. Khaw KT, Sneyd MJ, Compston J (1992) Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 305:273–277

    Article  PubMed  CAS  Google Scholar 

  3. Melin AL, Wilske J, Ringertz H, Saaf M (1999) Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging Clin Exp Res 11:200–207

    CAS  Google Scholar 

  4. Pfeifer M, Begerow B, Minne HW et al (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109:87–92

    Article  PubMed  CAS  Google Scholar 

  5. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634–639

    Article  PubMed  CAS  Google Scholar 

  6. Scharla SH, Scheidt-Nave C, Leidig G et al (1996) Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes 104:289–292

    Article  PubMed  CAS  Google Scholar 

  7. Jesudason D, Need AG, Horowitz M, O'Loughlin PD, Morris HA, Nordin BEC (2002) Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 31:626–630

    Article  PubMed  CAS  Google Scholar 

  8. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 80:752–758

    PubMed  CAS  Google Scholar 

  9. Lips P, Netelenbos JC, Jongen MJ et al (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res 4:85–93

    Article  PubMed  CAS  Google Scholar 

  10. Dixon T, Mitchell P, Beringer T et al (2006) An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin 22:405–415

    Article  PubMed  CAS  Google Scholar 

  11. Garnero P, Munoz F, Sornay-Rendu E, Delmas PD (2007) Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 40:716–722

    Article  PubMed  CAS  Google Scholar 

  12. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293:2257–2264

    Article  PubMed  CAS  Google Scholar 

  13. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL (2005) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev CD000227

  14. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P (2007) Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415–1423

    Article  PubMed  CAS  Google Scholar 

  15. Webb AR, Pilbeam C, Hanafin N, Holick MF (1990) An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 51:1075–1081

    PubMed  CAS  Google Scholar 

  16. Dawson-Hughes B, Harris SS, Dallal GE (1997) Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 65:67–71

    PubMed  CAS  Google Scholar 

  17. Holick MF (1995) Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61:638S–645S

    PubMed  CAS  Google Scholar 

  18. Heaney RP (2006) Barriers to optimizing vitamin D3 intake for the elderly. J Nutr 136:1123–1125

    PubMed  CAS  Google Scholar 

  19. Roy DK, O'Neill TW, Finn JD et al (2003) Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 14:19–26

    Article  PubMed  CAS  Google Scholar 

  20. Schroder HM, Erlandsen M (1993) Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5–18.5 years. J Orthop Trauma 7:525–531

    Article  PubMed  CAS  Google Scholar 

  21. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501

    Article  PubMed  CAS  Google Scholar 

  22. Holick MF (2002) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9:87–98

    Article  CAS  Google Scholar 

  23. Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 84:602–609

    PubMed  CAS  Google Scholar 

  24. Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351:805–806

    Article  PubMed  CAS  Google Scholar 

  25. Lips P, Duong T, Oleksik A et al (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212–1221

    Article  PubMed  CAS  Google Scholar 

  26. Wu F, Staykova T, Horne A et al (2003) Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 116:U536

    PubMed  Google Scholar 

  27. Angus RM, Sambrook PN, Pocock NA, Eisman JA (1989) A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 89:209–214

    PubMed  CAS  Google Scholar 

  28. Lucas JA, Bolland MJ, Grey AB et al (2005) Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int 16:1641–1648

    Article  PubMed  CAS  Google Scholar 

  29. Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809

    Article  PubMed  CAS  Google Scholar 

  30. Rosen CJ, Brown S (2003) Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 348:1503–1504

    Article  PubMed  Google Scholar 

  31. Adams JS, Kantorovich V, Wu C, Javanbakht M, Hollis BW (1999) Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 84:2729–2730

    Article  PubMed  CAS  Google Scholar 

  32. Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N (2008) Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19:1621–1628

    Article  PubMed  CAS  Google Scholar 

  33. Diamond TH, Ho KW, Rohl PG, Meerkin M (2005) Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 183:10–12

    PubMed  Google Scholar 

  34. Flicker L, MacInnis RJ, Stein MS et al (2005) Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 53:1881–1888

    Article  PubMed  Google Scholar 

  35. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469

    Article  PubMed  CAS  Google Scholar 

  36. Heikinheimo RJ, Inkovaara JA, Harju EJ et al (1992) Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105–110

    Article  PubMed  CAS  Google Scholar 

  37. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF (1998) Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8:222–230

    Article  PubMed  CAS  Google Scholar 

  38. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204–210

    PubMed  CAS  Google Scholar 

  39. Viljakainen HT, Palssa A, Kärkkäinen M, Jakobsen J, Lamberg-Allardt C (2006) How much vitamin D3 do the elderly need? J Am Coll Nutr 25:429–435

    PubMed  CAS  Google Scholar 

  40. Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842–856

    PubMed  CAS  Google Scholar 

  41. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288–294

    PubMed  CAS  Google Scholar 

  42. Vieth R (2006) Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 136:1117–1122

    PubMed  CAS  Google Scholar 

  43. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716

    Article  PubMed  CAS  Google Scholar 

  44. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  PubMed  CAS  Google Scholar 

  45. Bouillon R, Norman AW, Lips P (2007) Vitamin D deficiency. N Engl J Med 357:1980–1981

    Article  PubMed  CAS  Google Scholar 

  46. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S–1688S

    PubMed  CAS  Google Scholar 

  47. Bolland MJ, Grey AB, Ames RW et al (2007) The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on diagnosis of vitamin D sufficiency. Am J Clin Nutr 86:959–964

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are grateful to API Consumer Brands for providing the study medication.

Funding

This study was supported by the Health Research Council of New Zealand

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. R. Reid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bacon, C.J., Gamble, G.D., Horne, A.M. et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 20, 1407–1415 (2009). https://doi.org/10.1007/s00198-008-0814-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0814-9

Keywords

Navigation